SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer. - Wikidata - wikimedia - TriplyDB

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

http://www.wikidata.org/entity/Q37533348

about

Genomic analysis of drug resistant small cell lung cancer cell lines by combining mRNA and miRNA expression profiling.Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.Constitutive activity of the androgen receptor.Small non-coding RNA deregulation in endometrial carcinogenesis.miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2.Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.

P2860

Q33751052-2431B721-3AC1-40FD-9310-9A6343E70EBD Q33911829-770938D7-C4C0-47AB-AABA-B8BF47C1B21C Q34051993-D53E3A45-8167-492D-B8F6-1AE7ECCCB637 Q34775572-9052C1D5-A6D7-4631-90F5-30625872A037 Q35741534-CFB0A62C-DD57-4B68-A45E-D1FA9A80B458 Q35794952-E89BC7A1-2340-404E-B468-29399E8C5D3C Q36213718-49E1E2BC-15E3-4EC6-A485-C78E4070EBE3 Q36328751-71942721-C5BB-4670-A10E-1244CAF28B4D Q37569984-3ECBB193-EB45-4068-A2DA-411051E90464 Q38707571-7216D8B6-125F-40BB-8473-FC8E0879BC1E Q38762346-48E698B5-388F-4DFA-9FA0-D7285DAE90DE Q38914864-AA6149F5-37BD-47FF-9503-766EBA352FD2 Q52721250-B17107DE-F527-4D54-92B6-AD4FBC6041DC

P2860

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

http://www.wikidata.org/entity/Q37533348

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@en

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@nl

type

label

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@en

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@nl

prefLabel

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@en

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.

@nl

P1433

Q37533348-3051C7E4-A71C-4130-8384-241670EEE8DA

P1476

Q37533348-D9E8F4BB-9EE8-4786-A119-DD4D102B0D8B

P2093

Q37533348-4DBF001B-7E08-4B23-AE35-E19B8F4EEE4B

Q37533348-70464120-BCCA-4F27-9720-B7A5EC8AED86

Q37533348-84E0DD78-D3F8-4227-BE24-F4CA773EB6C6

Q37533348-8C933E7E-6D1C-4E85-B3C4-E2F07E7F4C06

Q37533348-B44F89D3-9EE9-4A13-9134-26FC7C82EB49

Q37533348-B739B113-D16C-49AA-87B8-C824ED256449

Q37533348-BDF9B57B-C510-4FAF-BDD9-9E0F46E7EFF9

Q37533348-C7532443-00EA-456F-8EA3-316D0F70A0A4

Q37533348-DB540E73-D51B-41AC-BDE1-19343501392A

Q37533348-EE71BD8D-2B15-420A-B650-EA8D0E6BDBA3

P2860

Q37533348-0771F757-801C-46A0-AF28-739B6ADF5A6E

Q37533348-0957312A-2517-4022-8644-AB6E2435D393

Q37533348-0A080C67-7D96-4C01-88D1-98D5B892C3F1

Q37533348-12F4BF5D-03A1-49AA-8EC4-BD3119CF8C46

Q37533348-1532582D-084B-4302-81A7-3D0291E0B863

Q37533348-15915270-4D7E-4DE5-8B0E-5FD7C7672C7A

Q37533348-24547DC7-39A7-4509-860E-E787D042443F

Q37533348-25BCF3D9-4A53-4944-A8B3-44C53B2F2C69

Q37533348-264C574D-B75A-44DC-8329-5D2059A072F0

Q37533348-351717BE-3E64-4586-A37B-673B36BB2346

P304

Q37533348-DB47C558-0E53-4056-A48D-B44887FDD329

P31

Q37533348-0C25145A-12D0-4F9C-ABF3-D4E25EF3F461

P356

Q37533348-31A3CE59-E82D-4D05-99AE-53D79FF5C653

P433

Q37533348-7455FF14-93A2-4310-BD68-26D634FBED6E

P478

Q37533348-5BB3219A-19B6-4CD2-9DD8-BF0B6D7D4625

P50

Q37533348-07862303-783C-4D8E-8E2D-2685EC24F038

Q37533348-A11BCB2D-6F1B-460D-BD4A-BC7639487094

P577

Q37533348-F4D1D14E-51B3-42E4-A978-55C72069440A

P5875

Q37533348-BB6B3C44-3EC6-461C-AE3C-F27759DBD57F

P698

Q37533348-9E14E2AA-6A09-4620-82E5-D7CADCC73331

P932

Q37533348-5285D588-C251-4390-9D48-2A9C29320E65

P356

P1433

Endocrine-related cancer

P1476

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

@en

P2093

Dimo Dietrich

http://www.w3.org/2001/XMLSchema#string

Eberhard Gunsilius

http://www.w3.org/2001/XMLSchema#string

Georg Schäfer

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Helmut Klocker

http://www.w3.org/2001/XMLSchema#string

Iris E Eder

http://www.w3.org/2001/XMLSchema#string

Johann Kern

http://www.w3.org/2001/XMLSchema#string

Martin Puhr

http://www.w3.org/2001/XMLSchema#string

Philipp Ofer

http://www.w3.org/2001/XMLSchema#string

Stephan Geley

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor

A family of cytokine-inducible inhibitors of signalling

A new protein containing an SH2 domain that inhibits JAK kinases

VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases

Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer

Cancer statistics, 2010

Gigantism in mice lacking suppressor of cytokine signalling-2

P304

175-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/ERC-13-0446

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Rainer

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258953976

http://www.w3.org/2001/XMLSchema#string

P698

24280133

http://www.w3.org/2001/XMLSchema#string

P932

3907181

http://www.w3.org/2001/XMLSchema#string